SCHEMBL4252452

SCHEMBL4252452

OC(Cc1ccccc1)c1cccnn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.40
SLC6A2 P23975 3/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
CES1 P23141 1/20 0.39
TRPA1 O75762 3/20 0.38
EPHX1 P07099 1/20 0.38
IDO1 P14902 1/20 0.36
ALPI P09923 1/20 0.36
PKM P14618 1/20 0.36
PTGS1 P23219 1/20 0.36
XIAP P98170 1/20 0.36
SLC7A5 Q01650 1/20 0.36
TAAR1 Q96RJ0 2/20 0.35
MAOA P21397 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CYP2A6 P11509 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
SLC6A9 P48067 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2162150 0.80 CES1 (0.52) CES1TRPA1
SCHEMBL7562251 0.80 SLC6A2 (0.55) CYP1A2SLC6A2SLC6A4SLC6A3CES1
SCHEMBL3712032 0.80 CYP1A2 (0.46) CYP1A2SLC6A2SLC6A4SLC6A3EPHX1
SCHEMBL27946805 0.77 SLC6A2 (0.48) CYP1A2SLC6A2SLC6A4SLC6A3TAAR1
SCHEMBL27813115 0.77 SLC6A2 (0.48) CYP1A2SLC6A2SLC6A4SLC6A3TAAR1
SCHEMBL12495184 0.77 TAAR1 (0.41) CYP1A2IDO1TAAR1SLC6A9CYP3A4
SCHEMBL6839728 0.77 P2RX7 (0.35) CYP1A2SLC6A9
SCHEMBL27833164 0.76 SLC6A2 (0.47) CYP1A2SLC6A2SLC6A4SLC6A3TAAR1
SCHEMBL28595047 0.74 GOT1 (0.34) CYP1A2SLC6A9
SCHEMBL6691295 0.74 HIF1A (0.43) CYP1A2SLC6A2SLC6A4SLC6A3TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081931-A2 FUSED HETEROCYCLIC DERIVATIVES USEFUL AS INHIBITORS OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR Amgen Inc. (US) 2009-07-29 EP disclosed
WO-2008008539-A2 FUSED HETEROCYCLIC DERIVATIVES USEFUL AS INHIBITORS OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR AMGEN INC. (US) 2008-01-17 WO disclosed